Your session is about to expire
← Back to Search
Brachytherapy
Seed Implants for Prostate Cancer
Phase 4
Waitlist Available
Led By Brian J Moran, MD
Research Sponsored by Prostate Cancer Foundation of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
I-PSS score < 25 (alpha blockers allowed)
Low and Low-Intermediate Risk prostate cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will compare two types of prostate cancer treatment in terms of patient quality of life.
Who is the study for?
Men over 40 with early-stage prostate cancer (T1c-T2b, N0, M0), no major medical or psychiatric illnesses, and a prostate size ≤ 60 cc. They must not have had previous treatments like hormone therapy or pelvic radiation, no hip replacements, and be able to consent to the study.Check my eligibility
What is being tested?
The trial is comparing two types of radioactive seed implants for prostate brachytherapy: ThinStrand with thinner needles versus RapidStrand with standard needles. Quality of life post-treatment will be assessed using the EPIC questionnaire at set intervals.See study design
What are the potential side effects?
Possible side effects include urinary problems, bowel issues, and sexual dysfunction related to the implantation procedure or radioactivity from the seeds affecting nearby tissues.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My prostate symptoms are mild to moderate.
Select...
My prostate cancer is classified as low or low-intermediate risk.
Select...
My prostate cancer is in the early stages and hasn't spread.
Select...
I am 40 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Health related quality of life including urinary, bowel and sexual function as measured by the EPIC questionnaire
Trial Design
2Treatment groups
Active Control
Group I: 20 g needleActive Control2 Interventions
Thin Strand
Group II: Iodine-125 standard 18 g needleActive Control2 Interventions
Rapidstrand
Find a Location
Who is running the clinical trial?
Prostate Cancer Foundation of ChicagoLead Sponsor
1 Previous Clinical Trials
1 Trials studying Prostate Cancer
Brian J Moran, MDPrincipal InvestigatorChicago Prostate Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer has spread to nearby lymph nodes.My prostate symptoms are mild to moderate.My prostate cancer is classified as low or low-intermediate risk.I have had major surgery for prostate cancer.I have had radiation therapy to my pelvic area before.I have had surgery for an enlarged prostate.I have received hormone therapy before.I have had a prostate surgery known as TURP.My prostate cancer is in the early stages and hasn't spread.I am 40 years old or older.My cancer has spread to distant parts of my body.
Research Study Groups:
This trial has the following groups:- Group 1: 20 g needle
- Group 2: Iodine-125 standard 18 g needle
Awards:
This trial has 3 awards, including:- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts still open for this clinical trial?
"The clinical trial listing on clinicaltrials.gov states that this medical study, originally launched April 1st 2010 and last modified February 11th 2013, is not currently seeking patients. However, there are 1321 other trials actively looking for participants at present."
Answered by AI
What potential perils are associated with a 20 g syringe?
"The safety of a 20 g needle is rated highly at the score of 3, as this particular treatment has been officially approved and its efficacy validated through extensive testing phases."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger